Please assess the completion status of the following clinical trial:

Trial Title: Protein Supplementation in Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 4.0

Eligibility Criteria:
Inclusion criteria:~* On hemodialysis for more than 3 months, on a thrice weekly hemodialysis program.~* Adequately dialyzed (Kt/V \> 1.2).~* Age 18-75~Exclusion criteria:~* Pregnant women.~* Severe unstable underlying disease besides commonly associated with end stage renal disease. Cardiac patients that are stable will be included.~* Patients hospitalized within the last month prior to the study.~* Patients with malfunctioning arterial-venous access \[recirculation and/or blood flow \< 500 ml/min for an arterial-venous graft (AVG) or \<400 ml/min for an arterial-venous fistula (AVF)\] Patients receiving steroids and/or other immunosuppressive agents.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): 30 ml per serving
- 2 (Type: ACTIVE_COMPARATOR): 60 ml per serving
- 3 (Type: NO_INTERVENTION): chronic hemodialysis patients
- 4 (Type: NO_INTERVENTION): healthy subjects

Based on this trial design, predict the completion outcome and termination type (if applicable).